BIOAVAILABILITY AND ACCEPTABILITY OF A DISPERSIBLE FORMULATION OF LEVODOPA-BENSERAZIDE IN PARKINSONIAN-PATIENTS WITH AND WITHOUT DYSPHAGIA

被引：25

作者：

BAYER, AJ

DAY, JJ

FINUCANE, P

PATHY, MSJ

机构：

来源：

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 1988年 / 13卷 / 03期

关键词：

D O I：

10.1111/j.1365-2710.1988.tb00179.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：191 / 194

页数：4

相关论文

共 6 条

[1] SYSTEMIC AVAILABILITY OF ORALLY-ADMINISTERED L-DOPA IN THE ELDERLY PARKINSONIAN PATIENT [J].

EVANS, MA ;

TRIGGS, EJ ;

BROE, GA ;

SAINES, N .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (03) :215-221

[2] THE PHARMACOKINETICS OF INTRAVENOUS AND ORAL LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE WHO EXHIBIT ON-OFF FLUCTUATIONS [J].

HARDIE, RJ ;

MALCOLM, SL ;

LEES, AJ ;

STERN, GM ;

ALLEN, JG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (04) :429-436

[3] PARKINSONS-DISEASE - DISABILITY, REVIEW, AND MANAGEMENT [J].

MUTCH, WJ ;

STRUDWICK, A ;

ROY, SK ;

DOWNIE, AW .

BRITISH MEDICAL JOURNAL, 1986, 293 (6548) :675-677

[4] THE EFFECT OF CARBIDOPA ON THE PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED LEVODOPA - THE MECHANISM OF ACTION IN THE TREATMENT OF PARKINSONISM [J].

NUTT, JG ;

WOODWARD, WR ;

ANDERSON, JL .

ANNALS OF NEUROLOGY, 1985, 18 (05) :537-543

[5]

OXTOBY M, 1981, SURVEY PATIENTS CONT

[6] VARIABILITY OF L-DOPA ABSORPTION IN MAN [J].

WADE, DN ;

MEARRICK, PT ;

BIRKETT, DJ ;

MORRIS, J .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1974, 4 (02) :138-143